إعلان
إعلان
FLGT
Fulgent Genetics, Inc. Common Stock
27.89
USDبرعاية
-0.12
-0.41%
٠٨ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
27.91
+0.02
+0.07%
تقارير أرباح FLGT
النسبة الإيجابية المفاجئة
FLGT تفوق 28 من 37 آخر التقديرات.
76%
التقرير التالي
بيانات التقرير القادم
٢٦ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$87.09M
/$0.03
التغير الضمني من Q3 25 (Revenue/ EPS)
+3.59%
/-78.57%
التغير الضمني من Q4 24 (Revenue/ EPS)
+14.27%
/-25.00%
Fulgent Genetics, Inc. Common Stock earnings per share and revenue
On ٠٧ نوفمبر ٢٠٢٥, FLGT reported earnings of 0.14 USD per share (EPS) for Q3 25, beating the estimate of -0.22 USD, resulting in a 161.46% surprise. Revenue reached 84.07 مليون, compared to an expected 83.06 مليون, with a 1.22% difference. The market reacted with a +18.15% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 المحللين forecast an EPS of 0.03 USD, with revenue projected to reach 87.09 مليون USD, implying an نقصان of -78.57% EPS, and زيادة of 3.59% in Revenue from the last quarter.
الأسئلة الشائعة
What were Fulgent Genetics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Fulgent Genetics, Inc. Common Stock reported EPS of $0.14, beating estimates by 161.46%, and revenue of $84.07M, 1.22% above expectations.
How did the market react to Fulgent Genetics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 18.15%, changed from $22.31 before the earnings release to $26.36 the day after.
When is Fulgent Genetics, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٢٦ فبراير ٢٠٢٦.
What are the forecasts for Fulgent Genetics, Inc. Common Stock's next earnings report?
Based on 5
المحللين, Fulgent Genetics, Inc. Common Stock is expected to report EPS of $0.03 and revenue of $87.09M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان